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Abstract
Background: The current millennium has seen a steep rise in the number, size and case-fatalities of cholera outbreaks in
many African countries. Over 40,000 cases of cholera were reported from Nigeria in 2010. Variants of Vibrio cholerae O1 El
Tor biotype have emerged but very little is known about strains causing cholera outbreaks in West Africa, which is crucial for
the implementation of interventions to control epidemic cholera.
Methodology/Principal Findings: V. cholerae isolates from outbreaks of acute watery diarrhea in Nigeria from December,
2009 to October, 2010 were identified by standard culture methods. Fifteen O1 and five non-O1/non-O139 strains were
analyzed; PCR and sequencing targeted regions associated with virulence, resistance and biotype were performed. We also
studied genetic interrelatedness among the strains by multilocus sequence analysis and pulsed-field gel electrophoresis.
The antibiotic susceptibility was tested by the disk diffusion method and E-test. We found that multidrug resistant atypical
El Tor strains, with reduced susceptibility to ciprofloxacin and chloramphenicol, characterized by the presence of the SXT
element, and gyrASer83Ile/parCSer85Leu alleles as well CTX phage and TCP cluster characterized by rstRElTor, ctxB-7 and tcpACIRS
alleles, respectively, were largely responsible for cholera outbreaks in 2009 and 2010. We also identified and characterized a
V. cholerae non-O1/non-O139 lineage from cholera-like diarrhea cases in Nigeria.
Conclusions/Significance: The recent Nigeria outbreaks have been determined by multidrug resistant atypical El Tor and
non-O1/non-O139 V. cholerae strains, and it seems that the typical El Tor, from the beginning of seventh cholera pandemic,
is no longer epidemic/endemic in this country. This scenario is similar to the East Africa, Asia and Caribbean countries. The
detection of a highly virulent, antimicrobial resistant lineage in Nigeria is worrisome and points to a need for vaccine-based
control of the disease. This study has also revealed the putative importance of non-O1/non-O139 V. cholerae in diarrheal
disease in Nigeria.
Citation: Marin MA, Thompson CC, Freitas FS, Fonseca EL, Aboderin AO, et al. (2013) Cholera Outbreaks in Nigeria Are Associated with Multidrug Resistant
Atypical El Tor and Non-O1/Non-O139 Vibrio cholerae. PLoS Negl Trop Dis 7(2): e2049. doi:10.1371/journal.pntd.0002049
Editor: Joseph M. Vinetz, University of California San Diego School of Medicine, United States of America
Received October 11, 2012; Accepted December 19, 2012; Published February 14, 2013
Copyright: ß 2013 Marin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: MAM, CCT and ELF obtained scholarships from Coordenação de Aperfeiçoamento de Pessoal de Nı́vel Superior (CAPES), the Conselho Nacional de
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and the toxin-coregulated pilus (TCP) encoded by the VPI-I
island, an essential factor for the colonization and also receptor for
the CTXW [5]. Classical and El Tor biotypes can be distinguished
by several genetic markers, such as rstR, tcpA, ctxB genes, the Vibrio
seventh pandemic island-I (VSP-I) and VSP-II, and by the number
of genes in the repeat toxin region (RTX) [2,6].
Recently, V. cholerae strains have been identified showing
markers of both classical and El Tor biotypes. These strains were
assigned as hybrid biotype, altered or El Tor variants presenting a
typical El Tor phenotype but with non-El Tor ctxB allele [2]. In
contrast to V. cholerae from the beginning of 7th cholera pandemic,
these atypical biotype strains are frequently multidrug resistant.
Changes in the antibiotic resistance profiles of V. cholerae are

Introduction
Vibrio cholerae is a human pathogen that causes cholera, a severe
acute watery diarrhea. There are more than 200 V. cholerae
serogroups, however only O1 and O139 are responsible for most
epidemics and pandemics of cholera. Serogroup O139 is restricted
to some parts of Asia but serogroup O1, classified as El Tor and
classical biotypes, was found worldwide [1,2]. The classical biotype
was responsible for severe clinical manifestation but the conventionally less virulent El Tor is better adapted to the environment
[3].
The major virulence factors are the cholera toxin (CT) encoded
by the ctxAB operon on the lysogenic bacteriophage CTXW [4],
PLOS Neglected Tropical Diseases | www.plosntds.org
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that originated from Nigeria in the beginning of the seventh
pandemic (1970’s), 16 isolates from three recent cholera outbreaks
and one strain isolated from a water sample. V. cholerae isolates
were identified and confirmed by standard culture methods at
isolation during the epidemics and again prior to molecular
characterization, and their serogroups and biotypes were identified
by biochemical and molecular methods [11].

Author Summary
Cholera is acute watery diarrhoea, severely dehydrating,
caused by Vibrio cholerae, a bacterium ubiquitous in
aquatic environments. Cholera is a global threat, particularly, in areas where sanitary conditions, such as drinking
water and sewage, are not available. Seven cholera
pandemics, all originating in Asia, occurred. The ongoing
pandemic, the 7th, has been caused by V. cholerae El Tor
biotype. Recently, El Tor has undergone genetic changes
and the strains being referred to as ‘‘atypical’’ El Tor are
rapidly replacing the original El Tor in many areas. The
atypical El Tor is characterized by multi-antibiotic resistance and changes in the major virulence determinants.
Cholera caused by atypical strains may be more clinically
severe. In Africa, cholera outbreaks are occurring with
increasing frequency and severity, as demonstrated by the
recent major outbreaks in Nigeria, Angola, Mozambique
and Zimbabwe. Here, we performed a comprehensive
characterization of V. cholerae isolated from different
recent outbreaks in Nigeria. Our results show that cholera
outbreaks in Nigeria are driven by atypical El Tor strains, as
worldwide.

PCR amplification and sequencing
PCR were performed targeting the genetic elements and regions
associated with V. cholerae virulence, resistance and biotype.
Virulence: VSP-II (VC0511, VC0513), VPI-I (tcpA), CTXW (ctxB),
heat stable enterotoxin (NAG-ST), type three secretion system
(T3SS), type VI secretion system (T6SS), enterotoxigenic hemolysin (hlyA) and RTX toxin (rtxA). Resistance: IntI1, IntI2 integrases
and variable regions from class 1 and 2 integrons and the 39
conserved sequence from class 1 integron, SXT element-integrase
gene and associated SXT resistance genes (floR, sul2, dfrA1 and
strAB) and genes related to quinolone resistance (gyrA, gyrB, parC
and parE). Biotype-specific repeat sequence transcriptional regulator (rstR), ctxB alleles and rfb gene specific for O1 serogroup 1
were also amplified. The nucleotide sequences of primers
employed are listed in Table 2.

associated with mutations in housekeeping genes as well as
acquisition of Integrative Conjugative Elements (ICEs) and other
mobile elements [7,8].
Africa is endemic for cholera and frequently affected by
outbreaks and epidemics, but there are few molecular epidemiology studies characterizing the determinants of these episodes.
Nigeria is in one of the three major current cholera foci in the
world [9]. In 2009, outbreaks began in Nigeria and other countries
at the Lake Chad basin [8] with the first reports coming from
Maiduguri, a city in the far north-east of the country.
Subsequently, outbreaks were reported from distant locales in
Northern and Western Nigeria, and in 2010 a severe outbreak,
which started in the Northern Nigeria spreading through the
country, was projected as the worst outbreak in Nigeria since
1991. This outbreak was marked with highest case-fatality [10],
what could be in part due to changes in V. cholerae infectivity even
though the organism remains largely unknown. It can be
hypothesized that an index strain has been disseminated crosscountry by human travel.
Here, we performed a comprehensive characterization of
representative V. cholerae strains from sequential outbreaks in
Nigeria (Maiduguri/2009, Bauchi/2010 and Ile Ife/2010) by
means of biotyping, multilocus sequence analysis (MLSA), pulsedfield gel electrophoresis (PFGE), as well as detection and
sequencing of virulence related genes and genetic determinants
of antimicrobial resistance. Our results show that recent cholera
outbreaks in Nigeria are driven by atypical El Tor strains and we
reported the presence of a non-O1/non-O139 lineage. The
atypical El Tor strains showed one unique combination of
virulence factor alleles and antimicrobial resistance to sulphonamides, trimethoprim/sulfamethoxazole, streptomycin, nalidixic
acid and reduced susceptibility to ciprofloxacin and chloramphenicol.

MLSA
Amplification and sequencing of the pyrH, recA and mdh
housekeeping genes were performed as described previously
(Table 2). Sequence alignments and phylogenetic analyses were
conducted using MEGA5 [12], based on the minimum evolution
method using concatenated sequences. Distance estimations were
obtained by Kimura two-parameter model. Two thousand
bootstrap replicates were performed.

Pulsed-Field Gel Electrophoresis
DNA macrorestriction profile was obtained using NotI enzyme
according to procedures described elsewhere [13]. The PFGE
dendrogram was constructed using BioNumerics software (Applied
Maths, Belgium). The similarity was determined by Dice
coefficient and cluster analysis was carried out with the
unweighted-pair group method using average linkages (UPGMA).

Disk diffusion susceptibility testing and Etest
Antibiotic susceptibility testing was performed by the disk
diffusion method, with Muller-Hinton Agar (Oxoid, Basingstoke,
UK), according to Clinical and Laboratory Standards Institute
(CLSI, 2010) standards. Strains were tested for resistance to:
Nalidixic acid, Ampicillin, Cephalothin, Cefpirom, Cefoxitin,
Cefuroxime sodium, Ciprofloxacin, Chloramphenicol, Erythromycin, Spectinomycin, Compound sulphonamides, Streptomycin,
Sulphamethoxazole, Sulphamethoxazole-Trimethopim, Trimethopim and Tetracycline. Minimum Inhibitory Concentrations
(MICs) for Ciprofloxacin and Chloramphenicol were determined
with the E-test (bioMerieux, Marcy l’Etoile, France).

Results
V. cholerae genotyping
We determined the genetic relationships among V. cholerae
strains consisting of Nigeria strains from 2009/2010 and 1971/
1972, one environmental isolate (2010) and well-characterized
reference strains. A MLSA tree based on concatenated sequence of
recA (666 bp), pyrH (456 bp) and mdh (591 bp) gene fragments were
constructed.

Materials and Methods
Bacterial strains
Twenty V. cholerae strains (15 O1 and five non-O1/non-O139
strains) isolated from outbreaks in Nigeria and reference strains
were analyzed (Table 1). We included in our analysis three isolates
PLOS Neglected Tropical Diseases | www.plosntds.org
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isolation

CL, classical; ET, El Tor; CIP, ciprofloxacin; CM, Chloramphenicol; ND, not determined;
*, ctxB genotype [16];
¥
, The genetic characteristics were determined by in silico analysis;
1
, VC1005 is an environmental isolate.
doi:10.1371/journal.pntd.0002049.t001
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Virulence related genes and biotypes

Table 1. Genetic and phenotypic characteristics of V. cholerae from Nigeria.
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Table 2. PCR primers used in this study.

Primer

Table 2. Cont.

Sequence (59-39)

Reference

recA-01-F

TGARAARCARTTYGGTAAAGG

[43]

recA-02-R

TCRCCNTTRTAGCTRTACC

pyrH-04-F

ATGASNACBAAYCCWAAACC

pyrH-02-R

GTRAABGCNGMYARRTCCA

mdh-1

ATGAAAGTCGCTGTTATT

mdh-2

GTATCTAACATGCCATCC

Primer

Housekeeping gene

SXTR

Sequence (59-39)

Reference

GCGAAGATCATGCATAGACC

[48]

ICE’s related genes

[43]

[44]

Biotype related genes
Serogroup O1

dfrA1 F

CGTGACAGGTTTGCGAATC

dfrA1 R

ATGGAGTGCCAAAGGTGAAC

strB F

CGTTGCTCCTCTTCTCCATC

sul2 R

CGTCAACATAACCTCGGACA

FloR F

GTGATTTTTGGTCCGCTCTC

FloR R

TCGGTAGGATGAAGGTGAGG

This study

This study

This study

Quinolone resistance

O1-F

GTTTCACTGAACAGATGGG

O1-R

GGTCATCTGTAAGTACAAC

[11]

rstR

gyrA_vF

AATGTGCTGGGCAACGACTGG

gyrA_vR

GTGCGCGATTTTCGACATACG

gyrB_vF

GGAAATGACTCGCCGTAAAGG

rstRclaF

TTTGCTACTTCTTCTTGGTT

gyrB_vR

GTTGTGATAACGCAGTTTATCTGGG

rstRETF

TGAGCATAAGCTCTTGATTT

parC_vF

GTCTGAGTTGGGTCTCTCGGC

rstAR

CCGTGAAAGTCATCAACG

parC_vR

AGAATCTCGGCAAACTTTGACAG

parE_vF

ATGCGTGCCAGCAAGAAAGTG

parE_vR

TTATCGCTGTCAGGGTCAATCC

oqxA_F

CTCGGCGCGATGATGCT

oqxA_R

CCACTCTTCACGGGAGACGA

qepA_F

GCAGGTCCAGCAGCGGGTAG

qepA_R

CTTCCTGCCCGAGTATCGTG

qnrA_F

TTCAGCAAGAGGATTTCTCA

qnrA_R

GGCAGCACTATTACTCCCAA

qnrB_F

CCTGAGCGGCACTGAATTTAT

qnrB_R

GTTTGCTGCTCGCCAGTCGA

qnrS_F

CAATCATACATATCGGCACC

qnrS_R

TCAGGATAAACAACAATACCC

qnrVC_F

AATTTTAAGCGCTCAAACCTCCG

qnrVC_R

TCCTGTTGCCACGAGCATATTTT

aac(69)-lb-cr _F

TTGCGATGCTCTATGAGTGGCTA

aac(69)-lb-cr _R

CTCGAATGCCTGGCGTGTTT

[45]

Virulence gene primers
VSP-II
VC0511F1

CTTGCTGCGTACTTAGCA

VC0511R1

AGTAGCATCGCTCTCGTA

VC0513F1

CTGAGGTGTTATATGTTTCG

VC0513R1

TCAAATTTCCTGACAGTTCC

[14]

[14]

VPI-I
TCPA1

CACGATAAGAAAACCGGTCAAGAG

TCPA2

ACCAAATGCAACGCCGAATGGAGC

[46]

CTX W
CT8

GCAGTCAGGTGGTCTTATTGC

CT10

TCCAGATATGCAATCCTCAG

[35]

NAG-ST
ST-1

GAGAAACCTATTCATTGCA

ST-2

GCAAGCTGGATTGCAAC

[47]

T3SS
vcsV2-F

GGCTCACCAGCTGTTATGGT

vcsV2-R

CGTATTGCACAAGTAGCCGC

[49]

[49]

[49]

[49]

[50]

[51]

[52]

[52]

[52]

[53]

[54]

doi:10.1371/journal.pntd.0002049.t002
This study

T6SS
vasH-F

TGTTGATGGGCGAGAGTCAC

vasH-R

ACGTGTGTGGCAGATACCAG

The MLSA tree showed three major clusters: (i) O1 El Tor,
O139 (MO10 strain) and the O1 clinical Nigeria strains,
including the ones from the 1970s (Figure 1), (ii) O1 classical
(O395 and RC27) and (iii) non-O1/non-O139 Nigeria strains.
The average pairwise difference for the V. cholerae concatenated
sequences was 1.5%. The divergence between the El Tor/O139
cluster and the classical cluster was 1.2% while the El Tor/O139
cluster and non-O1 cluster was 1.9%. This grouping was also
revealed by macrorestriction analysis using representative strains
of the MLSA analysis (Figure 2. VC04 and VC200 strains were
used as representative classical strains of the 6th pandemic and El
Tor VC121 of the beginning of the 7th pandemic from India. The
PFGE profiles showed that the Nigeria strains from the beginning
of the 7th pandemic (VC869, VC111, VC79) and the recent
strains (VC1004, VC832 and VC835) are genetically related and
shared a profile with El Tor VC121. The non-O1 strains
(VC1006 and VC998) shared a unique profile distinct from the
O1 strains.

This study

HlyA
VC0489F

AGATCAACTACGATCAAGCC

VC0489R

AGAGGTTGCTATGCTTTCTAC

[44]

RTX
rtxA1

GCGATTCTCAAAGAGATGC

rtxA2

CACTCATTCCGATAACCAC

[44]

Resistance gene primers
Integron related primers
INT1 F

AAAACCGCCACTGCGCCGTTA

INT1 R

GAAGACGGCTGCACTGAACG

INT2 F

GCGTTTTATGTCTAACAGTCC

INT2 R

AAGTAGCATCAGTCCATCC

[13]

[24]

SXT integrase
SXTF

TCGGGTATCGCCCAAGGGCA

PLOS Neglected Tropical Diseases | www.plosntds.org
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Figure 1. Genetic relatedness of Nigeria V. cholerae strains. The epidemic O1 Nigeria strains are within the El Tor/139 cluster and the Non-O1/
Non-O139 strains characterized a distinct cluster. This Minimum Evolution tree was constructed based on Kimura-two-parameter method using the
concatenated nucleotide sequences of recA, pyrH and mdh gene fragments. Two thousand bootstrap replicates were performed; bootstrap values are
given at the nodes. Vibrio mimicus MB451strain was used as outgroup.
doi:10.1371/journal.pntd.0002049.g001

while the more recently recovered 2009/10 O1 El Tor Nigeria
isolates harbor only VC0513 (Table 1), indicating that these
lineages carry a different version of VSP-II than earlier isolates.
The current non-O1 Nigeria strains were negative for both,
VC0511 and VC0513 loci.
The ctxB present in all Nigeria current O1 El Tor strains belong
to the atypical genotype 7, characterized by the non conservative
change His20Asn [16]. El Tor strains from the beginning of the 7th
pandemic in Nigeria, as worldwide, were characterized by the
canonical El Tor ctxB genotype 3 and keep their own repressor
rstRElTor gene of the CTX prophage.
Concerning the tcpA alleles, there are tcpAElTor, tcpAclassical and
tcpANonO1 disseminated among V. cholerae strains. All current O1
Nigeria strains harbor tcpACIRS allele (Table 1), recently described
in the CIRS101 strain, a V. cholerae O1 El Tor from Bangladesh,

Biotyping and virulence gene typing
PCR-verified serogroup analysis demonstrated that 15 of the 20
strains studied, belonged to serogroup O1 and five were non-O1
isolates (Table 1). V. cholerae O1 strains are classified into El Tor,
classical and atypical El Tor [2] based on tcpA (toxin co-regulated
pilin A), ctxB (cholera toxin B), rstR (repeat sequence transcriptional regulator), as well as variations in VSP-II (Vibrio seventh
pandemic island II). The VSP-II gene cluster characterizes the El
Tor strains, and comprises a region of ,24 ORFs. In this study, V.
cholerae O1 strains were genotyped based on sequence information
of rstR, ctxB, tcpA, VSP-II regions (locus VC0511 and VC0513).
We screened for the presence of two loci of the VSP-II, VC0511
and VC0513, which are considered the most variable loci in the
VSP-II island [14,15]. The Nigeria strains from 1970’s and the
prototypical N16961, were positive for VC0511 and VC0513 loci,
PLOS Neglected Tropical Diseases | www.plosntds.org
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Figure 2. Dendrogram of PFGE patterns of representative V. cholerae O1 and Non-O1/Non-O139 strains. The similarity was determined
using the Dice coefficient, and cluster analysis was performed using the UPGMA. The right panel shows the presence (dark box) and absence (light
box) of genomic traits. VC04 and VC200 belong to the classical lineage; VC121 is an India strain from the beginning of the 7th cholera pandemic.
doi:10.1371/journal.pntd.0002049.g002

2002 [17]. Based on these genotypes, the current epidemic V.
cholerae O1 strains from Nigeria are classified as atypical El Tor
biotype.
Although, the current non-O1/non-O139 Nigeria strains were
negative for rstR, ctxB, tcpA, VSP-II regions (locus VC0511 and
VC0513) as well NAG-ST and T3SS (vcsV2 gene), they are
positive for T6SS (vasH gene), hlyA and rtxA genes, all virulence
associated factors involved in diarrheiogenic property [18–21].
Therefore, a non-O1/non-O139 lineage harboring a set of
virulence determinants could be associated with a cholera-like
diarrhea [22].

presence of the SXT integrase gene, contrasting with non-O1 and
the O1 from the 1970’s (Table 1). No evidence was found for the
presence of class 1 and 2 integrons (which we sought by PCR for
intI1 and intI2, respectively. Table 1). We performed PCR targeting
ICE associated genes floR, sul2, dfrA1, and strAB, associated with
chloramphenicol, sulfamethozaxole, trimethoprim and streptomycin resistance, respectively [7,26]. All these genes were identified,
explaining the resistance profile, including reduced susceptibility to
chloramphenicol, of the current O1 strains.
Majority of the 2009/10 Nigeria O1 strains showed reduced
susceptibility to ciprofloxacin (Table 1) as well as resistance to
nalidixic acid. Quinolone resistance has been attributed to
mutations in gyrA (Ser83Ile) and in parC (Ser85Leu) [26,27] and
these alleles were found in these strains. We additionally screened
the 2009/10 isolates for horizontally transmitted quinoloneresistance genes qnrA, qnrB, qnrS, qnrVC, qepA, oqxAB and aac(69)Ib-cr. The isolates were all negative for all of these targets. None of
these resistance phenotypes or genotypes detected in the 2009/10
isolates were found in strains isolated in Nigeria during the1970’s.
Additionally, resistance phenotype and genes were not seen in the
2009/10 non-O1/non-O139 isolates, with the exception of the
environmental non-O1/non-O139 VC1005 strain, which showed
resistance to nalidixic acid attributable to mutations in gyrA and
parC (Table 1).

Characterization of elements associated with antibiotic
resistance
Antibiotic multidrug resistance is becoming increasingly common
among the atypical V. cholerae strains, mostly associated with
acquisition of genes and/or modification in the antibiotic target
genes [23]. According to our results, the current O1 Nigeria strains
were resistant to streptomycin, trimethoprim and sulfonamides. In
V. cholerae, these resistances, are frequently associated with class 1
and 2 integrons [24] and SXT element, which is a V. cholerae-derived
ICE (integrating and conjugative element) [25]. Thus, we investigated the presence of these elements in the Nigeria strains. All the
current O1 strains harbor an ICE element, determined by the
PLOS Neglected Tropical Diseases | www.plosntds.org
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genotypic profile was found in isolates from all three outbreaks
represented in this study (Table 1). Moreover, we found that the
2009/10 O1 Nigeria strains carried sul2, dfrA1 and floR genes,
conferring resistance to sulfonamides, trimethoprim, and intermediate susceptibility to chloramphenicol, respectively, and strA/B,
which confers to streptomycin resistance. These genes have been
associated with integrative and conjugative elements (ICEs) and the
2009/10 O1 Nigeria strains were positive for the SXT integrase,
indicating that these strains harbor an ICE. ICEs have been
identified in V. cholerae strains from Ghana [24], Kenya [36],
Mozambique [37] and Angola [7]. In contrast to the 2009/10
isolates, the Nigeria strains from the beginning of the 7th cholera
pandemic had the canonical El Tor allelic profile ctxB-3/tcpAElTor/
gyrASer83/parCSer85 and lacked most of the resistance genes.
Interestingly, as reported elsewhere [38], we found that a
lineage of V. cholerae non-O1/non-O139, lacking the major
virulence determinants and the resistance phenotype described
above, but harboring a set of virulence associated genes was cocirculating with atypical El Tor strains being recovered from
patients with cholera-like disease in Bauchi, Nigeria in 2010. This
outbreak followed the Maiduguri outbreak and were accompanied
by a slightly improved public engagement response. It is probable
that individuals with cholera-like disease are more likely to present
to health facilities when they have received information about an
on-going cholera outbreak. Our findings suggest that non-O1/
non-O139 V. cholerae may be important causes of endemic
diarrheal disease and outbreaks. Recovery of a similar strain from
water tested in Ile-Ife supports this possibility.
Population structure of clinical V. cholerae strains can be
influenced by epidemiological factors like transmission dynamics,
clonal expansion during epidemics, human travel, and selective
pressure from antimicrobial drugs. The data in our study showed
that recent outbreaks in Nigeria are caused by multidrug resistant
atypical El Tor O1 strains, which are reportedly highly virulent
[8,39–42], a common worrisome trend in the current cholera
outbreaks around the world. The data suggest that guidelines for
managing and containing cholera outbreaks in Nigeria (which
include, in addition to rehydration, using the antimicrobials
trimethoprim, and more recently ciprofloxacin) need to be
urgently revised. The data also show that V. cholerae non-O1/
non-O139 strains were involved in outbreaks in Nigeria suggesting
that interventions to control epidemic cholera such as improvements in water supplies and sanitation, as well as vaccination, may
result in broad gains.

Discussion
Since 1995 and over a period of more than a decade the
canonical El Tor has been replaced in Kolkata, India by atypical
El Tor. They were originally described in South Asia [2,28,29] but
recent reports have shown their spread to all continents, reaching
even Mexico [30] and Haiti [26]. Based only on ctxB genotyping,
atypical El Tor have already been reported in some African
countries, where cholera has become a serious public health threat
in recent years [7,8,31–35].
Despite the great impact from cholera, few investigators focused
on the molecular epidemiology of V. cholerae in West Africa. A
recent genomic survey of 154 isolates worldwide did not include
any isolates from West Africa [36]. Due to the plasticity of V.
cholerae resulting in the constant emergence of variants, surveillance
and characterization of outbreak strains, and their antibiotic
resistance determinants, is essential to defining the complex
scenario of cholera in this continent as well as worldwide.
Recently, it was shown that different V. cholerae O1 lineages were
responsible for cholera outbreaks in Ghana [35]. Here, we provide
evidence that different V. cholerae lineages are driving cholera
outbreaks in Nigeria.
Molecular typing of 20 V. cholerae strains from Nigeria, allowed us
to identify atypical O1 strains as well as a non-O1/non-O139
lineage. To date, there are only two studies performing molecular
characterization of V. cholerae strains causing cholera in Nigeria and
very few microbiological outbreak investigations [8,17]. Both
molecular studies focused on the allelic characterization of the
two major virulence genes and one of them addressed also the
quinolone resistance determinants. Talkington et al, who analyzed
two 2008 isolates from Nigeria, reported two profiles: ctxB-1/
tcpAElTor/rstRElTor and ctxB-1/tcpACIRS/rstRElTor [17]. Quilici and
collaborators analyzing ten strains from 2009 showed a unique
allelic profile: ctxB-7/tcpAElTor/rstRElTor [8]. They reported that
these isolates were identical to nine isolates from neighboring
Cameroon, which also borders the Lake Chad basin. These isolates
are temporally and geographically proximal to the 2009 Maiduguri
outbreak from which we obtained isolates VC832 and VC841 for
our study. In our study, considering these set of genes, the 12 V.
cholerae O1 strains, from 2009/2010 cholera outbreaks including the
2009 Maiduguri outbreak, presented a new combination of alleles:
ctxB-7/tcpACIRS/rstRElTor. Interestingly, a strain carrying same
combination of ctxB-7 and tcpACIRS alleles, as the profile identified
in this work, was characterized causing cholera in Cameroon and
Haiti in 2010 [17]. Strains from the 2010 Bauchi outbreak in North
Central Nigeria and the 2010 Ile-Ife outbreak, both evaluated in this
study, were also predominantly of the ctxB-7 and tcpACIRS genotype.
Therefore it is likely that these four genotypes were co-circulating in
the Chad basin at that time [8].
In the Quilici et al study [8], V. cholerae strains showed intermediate
susceptibility to chloramphenicol, reduced susceptibility to ciprofloxacin and resistance to trimethoprim/sulfamethoxazole, sulfonamides and nalidixic acid, and the gyrASer83Ile/parCSer85Leu alleles
related to quinolone resistance. This same resistance phenotypic and
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